← Back to Search

Voice-Activated Technology for Frailty (EngAGE Trial)

Phase 2
Recruiting
Led By Megan Huisingh-Scheetz, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Can hear spoken voice from 2-foot distance
Age greater than or equal to 65 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

EngAGE Trial Summary

This trial will test whether using EngAGE, an interactive voice-activated app, can help improve physical and social function in older adults compared to usual care.

Who is the study for?
This trial is for African American individuals aged 65 or older with at least two chronic conditions and moderate mobility issues. They must need some assistance to leave home, be able to read on a tablet screen, hear spoken voice from a distance, and have no severe cognitive impairments.Check my eligibility
What is being tested?
The study compares the effectiveness of EngAGE (a voice-activated app) versus usual care in improving physical and social functions of older adults. Participants will either use the app regularly or continue with their normal routines without it.See study design
What are the potential side effects?
Since this trial involves using an application rather than medication, traditional side effects are not expected. However, participants may experience frustration or fatigue when interacting with technology.

EngAGE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can hear someone speaking from 2 feet away.
Select...
I am 65 years old or older.
Select...
I need help to leave my house.

EngAGE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Timed Chair Stands
Secondary outcome measures
4 meter usual walk
Grip Strength
Loneliness
+2 more

EngAGE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EngAGEExperimental Treatment1 Intervention
Older adult subjects will receive an Alexa Echo Show that runs an exercise app called EngAGE.
Group II: Physical Exercise HandoutsActive Control1 Intervention
Older adults subjects will receive a paper booklet containing exercise instructions.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,003 Previous Clinical Trials
819,501 Total Patients Enrolled
3 Trials studying Frailty
167 Patients Enrolled for Frailty
Rush UniversityOTHER
40 Previous Clinical Trials
383,770 Total Patients Enrolled
National Opinion Research CenterOTHER
12 Previous Clinical Trials
243,947 Total Patients Enrolled

Media Library

Enhanced Engagement Clinical Trial Eligibility Overview. Trial Name: NCT05337514 — Phase 2
Frailty Research Study Groups: EngAGE, Physical Exercise Handouts
Frailty Clinical Trial 2023: Enhanced Engagement Highlights & Side Effects. Trial Name: NCT05337514 — Phase 2
Enhanced Engagement 2023 Treatment Timeline for Medical Study. Trial Name: NCT05337514 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still underway for the trial?

"As verified by clinicaltrials.gov, this medical trial is still recruiting patients after first being posted on October 25th 2022 and receiving its most recent update two days later."

Answered by AI
Recent research and studies
~113 spots leftby Jul 2025